Lyme Disease: Timing Matters

This recorded session with Dr. Daniel Griffin, MD, PhD, Chief of the Division of Infectious Diseases at Island Infectious Disease in New York, provides essential insights into the diagnosis and treatment of Lyme disease. Infection-associated chronic conditions, such as those triggered by Lyme disease, pose significant challenges to health care systems and patient quality of life. These conditions can lead to long-term health issues, making early and accurate diagnosis crucial.

OBJECTIVES

  • Understand the timing and treatment for post-exposure prophylaxis.
  • Understand diagnosis and treatment for early Lyme Disease.
  • Be able to diagnose and treat late Lyme Disease.

FREE ACCESS: The recorded webinar can be viewed here: https://vimeo.com/1097616444/a66da2cdba

SPEAKER

Dr. Griffin is a physician-scientist, who is board-certified in Internal Medicine and Infectious Disease with expertise in Global Health, Tropical Medicine, Parasitology, and Virology. He is Chief of the Division of Infectious Diseases at Island Infectious Disease and an Infectious Disease Physician and Clinical Instructor of Medicine at Columbia University. Dr. Griffin serves as President of Parasites without Borders and is one of the Directors of MicrobeTV. An active clinician and author, Dr. Griffin is an internationally invited speaker and one of the hosts of the popular podcasts This Week in Parasitism, This Week in Virology, and The Infectious Disease Puscast.

EARNING CREDIT

This module consists of a video recorded from a live webinar and is available to users who register and submit payment for access to the module.  The estimated time to complete the module is 60 minutes. After watching the video, complete the evaluation which is available in the description beneath the video.  Upon completion of the evaluation, you will be sent a certificate for the activity.  To obtain a certificate for the course, the evaluation must be completed.  A certificate will be sent through email within 5 days of completing the evaluation.

DISCLOSURES

Daniel Griffin, MD, PhD, CTrop is an advisor and speaker for Pfizer, Inc.
All relevant financial relationships have been mitigated.

None of the planners for this module have relevant financial relationships to disclose.

ACCREDITATION

The Hanley Center for Health Leadership and Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association’s Committee on Continuing Medical Education and Accreditation to provide Continuing Medical Education (CME) to physicians.